We also showed the significant elevation of plasma BST2 levels in CRC patients compared to normal controls and showed that BST2 may increase AUC after combining CEA for CRC detection, especially for stage 1-2 CRC detection (Figure 4). The gene discussed is CEACAM5; the disease is colorectal carcinoma.